Temporal artery biopsy...who needs one?

Area of Science:

• Rheumatology
• Internal Medicine
• Diagnostic Accuracy

Background:

• Giant cell arteritis (GCA) diagnosis relies on clinical criteria and temporal artery biopsy.
• The American College of Rheumatology (ACR) 1990 criteria provide a scoring system for GCA diagnosis.
• Evaluating the utility of ACR criteria in a real-world setting is crucial for optimizing diagnostic pathways.

Purpose of the Study:

• To assess the diagnostic performance of the ACR 1990 criteria for giant cell arteritis (GCA) over a 10-year period.
• To determine the impact of temporal artery biopsy results on diagnosis when using ACR criteria.
• To evaluate the necessity of temporal artery biopsies in patients with suspected GCA.

Main Methods:

• Retrospective cohort analysis of patients undergoing temporal artery biopsy over a decade.
• Application of the ACR 1990 five-point scoring system to assess diagnostic confidence.
• Comparison of ACR scores with temporal artery biopsy results to determine diagnostic yield.

Main Results:

• 111 patients were analyzed; 75 had an ACR score of 3 or 4 at presentation.
• Only one positive biopsy influenced the diagnosis, changing the ACR score from 2 to 3.
• Corticosteroid treatment prior to biopsy did not significantly affect biopsy yield.

Conclusions:

• An ACR score of 3 or more demonstrates high sensitivity (93.5%) and specificity (91.2%) for GCA diagnosis.
• In 68% of cases, clinical features were sufficient for confident GCA diagnosis without biopsy.
• Restricting temporal artery biopsies to cases where results may alter diagnosis can reduce biopsy rates by two-thirds without compromising accuracy.